MX337357B - Excipiente para tableteado a base de lactosa y celulosa. - Google Patents
Excipiente para tableteado a base de lactosa y celulosa.Info
- Publication number
- MX337357B MX337357B MX2011002950A MX2011002950A MX337357B MX 337357 B MX337357 B MX 337357B MX 2011002950 A MX2011002950 A MX 2011002950A MX 2011002950 A MX2011002950 A MX 2011002950A MX 337357 B MX337357 B MX 337357B
- Authority
- MX
- Mexico
- Prior art keywords
- lactose
- cellulose
- tableting aid
- based tableting
- aid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Abstract
La presente invención se refiere a un proceso para producir un granulado a base de lactosa y celulosa (derivado), un granulado que se obtiene por el proceso y su uso como un excipiente para tableteado.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102008047910A DE102008047910A1 (de) | 2008-09-19 | 2008-09-19 | Tablettierhilfsstoff auf Laktose- und Cellulosebasis |
PCT/EP2009/062203 WO2010031866A1 (de) | 2008-09-19 | 2009-09-21 | Tablettierhilfsstoff auf laktose- und cellulosebasis |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2011002950A MX2011002950A (es) | 2011-08-03 |
MX337357B true MX337357B (es) | 2016-02-29 |
Family
ID=41413349
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2011002950A MX337357B (es) | 2008-09-19 | 2009-09-21 | Excipiente para tableteado a base de lactosa y celulosa. |
Country Status (13)
Country | Link |
---|---|
US (1) | US8663684B2 (es) |
EP (1) | EP2344197B1 (es) |
KR (1) | KR101661256B1 (es) |
CN (1) | CN102202691B (es) |
BR (1) | BRPI0918530B1 (es) |
CA (1) | CA2737380C (es) |
DE (1) | DE102008047910A1 (es) |
ES (1) | ES2624231T3 (es) |
MX (1) | MX337357B (es) |
NZ (1) | NZ592331A (es) |
UA (1) | UA102865C2 (es) |
WO (1) | WO2010031866A1 (es) |
ZA (1) | ZA201101982B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102008047910A1 (de) | 2008-09-19 | 2010-03-25 | Molkerei Meggle Wasserburg Gmbh & Co. Kg | Tablettierhilfsstoff auf Laktose- und Cellulosebasis |
CN102258495B (zh) * | 2011-07-13 | 2013-01-30 | 石家庄四药有限公司 | 头孢丙烯片及其制备方法 |
PL2797581T3 (pl) * | 2011-12-27 | 2020-10-05 | Amgen (Europe) GmbH | Formulacje (+)-2-[1-(3-etoksy-4-metoksy-fenylo)-2-metanosulfonylo-etylo]- 4acetyloaminoizoindolino-1,3-dionu |
NZ747657A (en) | 2012-11-02 | 2019-12-20 | Murray And Poole Entpr Ltd | Treatment or prevention of cardiovascular events via the administration of a colchicine derivative |
MY198452A (en) | 2013-04-16 | 2023-08-29 | Murray And Poole Enterprises Ltd | Sustained-release formulations of colchicine and methods of using same |
CN114504559B (zh) * | 2022-03-01 | 2023-05-05 | 安徽山河药用辅料股份有限公司 | 一种药用辅料乳糖纤维素共处理物的制备方法 |
WO2024060048A1 (zh) * | 2022-09-21 | 2024-03-28 | 浙江汉脉医药科技有限公司 | 糖类缓释组合物及其制备方法 |
Family Cites Families (93)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3045488A1 (de) | 1980-12-03 | 1982-07-01 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung von stabilisierten kallikreinhaltigen tabletten |
DE3505433A1 (de) * | 1985-02-16 | 1986-08-21 | Basf Ag, 6700 Ludwigshafen | Direkttablettierhilfsmittel |
DE3506276C1 (de) | 1985-02-22 | 1986-04-24 | Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring | Direkttablettiermittel |
DD249186A1 (de) | 1986-05-26 | 1987-09-02 | Univ Halle Wittenberg | Herstellungsverfahren einer neuen glibenclamid-arzneiform mit hoher bioverfuegbarkeit |
EP0610848B1 (de) | 1993-02-11 | 1997-05-21 | Hoechst Aktiengesellschaft | Verfahren zur Herstellung von dichtgesinterten keramischen Bauteilen aus Siliziumnitrid mit hoher mechanischer Festigkeit |
CZ289649B6 (cs) | 1994-07-22 | 2002-03-13 | Krka, Tovarna Zdravil. P.O. | Pevné lékové formy se spolehlivým uvolňováním aktivní sloľky alprazolamu a způsob jejich přípravy |
DE19602757A1 (de) | 1996-01-26 | 1997-07-31 | Boehringer Mannheim Gmbh | Feste Instant-Release-Darreichungsformen und Verfahren zu ihrer Herstellung |
AU2068797A (en) | 1996-01-29 | 1997-08-20 | Edward Mendell Co. Inc. | Sustained release excipient |
US5762961A (en) | 1996-02-09 | 1998-06-09 | Quadrant Holdings Cambridge Ltd. | Rapidly soluble oral solid dosage forms, methods of making same, and compositions thereof |
CA2274832A1 (en) * | 1996-12-12 | 1998-06-18 | Dds Drug Delivery Service Gesellschaft Zur Forderung Der Forschung In Ph Armazeutischer Technologie Und Biopharmazie Mbh | Preparation in form of a matrix material-auxiliary agent compound containing optionally an active substance |
DE19651734C2 (de) | 1996-12-12 | 1999-05-12 | Dds Drug Delivery Service Ges | Zubereitung in Form eines Polymer-Hilfsstoff-Compounds und/oder eines Polymer-Wirkstoff-Compounds und Verfahren zu dessen Herstellung sowie dessen Verwendung zur Herstellung von Tabletten und/oder anderen größeren Matrixeinheiten |
DE19749897C1 (de) | 1997-11-12 | 1999-08-26 | Dds Drug Delivery Service Ges | Zubereitung in Form eines Lipid-Hilfsstoff-Compounds und/oder eines Lipid-Wirkstoff-Compounds und Verfahren zu dessen Herstellung sowie dessen Verwendung zur Herstellung von Tabletten und/oder anderen größeren Matrixeinheiten |
CA2209868C (en) | 1997-08-15 | 2001-08-14 | Bernard Charles Sherman | Pharmaceutical compositions comprising cefuroxime axetil |
EE200000186A (et) | 1997-11-03 | 2001-04-16 | Janssen Pharmaceutica N.V. | Osake, selliste osakeste valmistamismeetod ja kasutamine, farmatseutiline doosivorm ja selle valmistamismeetod, tahke dispersioon ja farmatseutiline pakend |
US6168805B1 (en) | 1998-05-07 | 2001-01-02 | Endo Pharmaceuticals, Inc. | Aqueous process for manufacturing paroxetine solid dispersions |
PE20000559A1 (es) | 1998-05-27 | 2000-07-05 | Merck & Co Inc | Formulacion de tabletas comprimidas de efavirenz |
EP1332757B1 (en) | 1998-05-27 | 2012-06-13 | Merck Sharp & Dohme Corp. | Efavirenz compressed tablet formulation |
MA26693A1 (fr) | 1998-09-28 | 2004-12-20 | Glaxo Group Ltd | Compositions pour administration par voie buccale |
EP1124541B1 (de) | 1998-09-30 | 2003-11-26 | Basf Aktiengesellschaft | Verwendung von wasserlöslichen oder wasserdispergierbaren polyether-haltigen pfropfpolymerisaten als überzugsmittel, bindemittel und/oder filmbildender hilfsstoff in pharmazeutischen darreichungsformen |
US20040013613A1 (en) | 2001-05-18 | 2004-01-22 | Jain Rajeev A | Rapidly disintegrating solid oral dosage form |
ID29270A (id) | 1998-11-20 | 2001-08-16 | Rtp Pharma Inc | Partikel-partikel mikro yang distabilkan oleh fosfolipid yang dapat menyebar |
US6716453B1 (en) | 1999-05-20 | 2004-04-06 | Verion, Inc. | Method for increasing the active loading of compressible composition forms |
CZ20014379A3 (cs) | 1999-06-11 | 2002-08-14 | Ranbaxy Laboratories Limited | Kompozice k maskování chuti a způsob její přípravy |
UA72922C2 (uk) | 1999-08-03 | 2005-05-16 | Ліллі Айкос Ллк | ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ З <font face="Symbol">b</font>-КАРБОЛІНОМ (ВАРІАНТИ) ТА СПОСІБ ЛІКУВАННЯ СЕКСУАЛЬНОЇ ДИСФУНКЦІЇ |
US6419956B1 (en) | 1999-12-30 | 2002-07-16 | Ancile Pharmaceuticals | Odor-masking coating for a pharmaceutical preparation |
DE50100265D1 (de) | 2000-03-23 | 2003-07-03 | Basf Drucksysteme Gmbh | Verwendung von Pfropfcopolymeren zur Herstellung lasergravierbarer Reliefdruckelementen |
US6761901B1 (en) | 2000-05-02 | 2004-07-13 | Enzrel Inc. | Liposome drug delivery |
US6316029B1 (en) | 2000-05-18 | 2001-11-13 | Flak Pharma International, Ltd. | Rapidly disintegrating solid oral dosage form |
US20020001617A1 (en) | 2000-05-26 | 2002-01-03 | Chang-Hyun Lee | Rapidly disintegrating tablet and process for the manufacture thereof |
US6413590B1 (en) | 2000-05-31 | 2002-07-02 | Rexam Graphics Inc. | Glossy ink jet medium |
JP3415835B2 (ja) | 2000-06-30 | 2003-06-09 | 山之内製薬株式会社 | 口腔内速崩壊錠およびその製造法 |
ES2215696T3 (es) | 2000-07-13 | 2004-10-16 | Vitatene, S.A. | Metodo para la produccion de una formulacion dispersable en agua que contiene carotenoides. |
DE60036205T2 (de) | 2000-07-27 | 2008-05-21 | Roquette Frères | Granulat bestehend aus Stärke und Laktose |
IN192750B (es) | 2000-12-15 | 2004-05-15 | Ranbaxy Lab Ltd | |
US6720003B2 (en) | 2001-02-16 | 2004-04-13 | Andrx Corporation | Serotonin reuptake inhibitor formulations |
US6610326B2 (en) | 2001-02-16 | 2003-08-26 | Andrx Corporation | Divalproex sodium tablets |
SE0101329D0 (sv) | 2001-04-12 | 2001-04-12 | Astrazeneca Ab | Pharmaceutical formulation |
WO2002100407A1 (en) | 2001-06-12 | 2002-12-19 | Smartrix Technologies Inc. | Itraconazole granulations: pharmaceutical formulations for oral administration and method of preparing same |
US20040241247A1 (en) | 2001-09-04 | 2004-12-02 | Sheskey Paul J | Process for dispersing a fluid in solid particles |
JP2005506323A (ja) | 2001-09-05 | 2005-03-03 | ベクトゥラ・リミテッド | 経口送達用機能性散剤 |
DE10152351B4 (de) | 2001-10-18 | 2005-09-22 | Schering Ag | Feste Arzneimittelformulierung für ein Piperazinharnstoffderivat |
US6753017B2 (en) | 2001-11-07 | 2004-06-22 | Jrs Pharma Lp | Process for preparing dry extracts |
WO2003048666A1 (en) | 2001-11-29 | 2003-06-12 | Penwest Pharmaceutical Company | Process for co-spray drying liquid herbal extracts with dry silicified mcc |
US20030206978A1 (en) | 2001-11-29 | 2003-11-06 | Bob Sherwood | Agglomerated particles including an active agent coprocessed with silicified microcrystalline cellulose |
US7179488B2 (en) | 2001-11-29 | 2007-02-20 | Bob Sherwood | Process for co-spray drying liquid herbal extracts with dry silicified MCC |
EP1509204A4 (en) | 2001-11-29 | 2005-07-13 | Rettenmaier & Soehne Gmbh & Co | AGGLOMERATED PARTICLES WITH AN ACTIVE SUBSTANCE PREPARED WITH MELTED MICROCRYSTALLINE CELLULOSE |
EP1467745A2 (en) | 2002-01-10 | 2004-10-20 | Lupin Limited | Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders |
DE10207427A1 (de) | 2002-02-21 | 2003-09-04 | Basf Ag | Schnelllöslicher Filmüberzug basierend auf Polyvinylalkohol-Polyether-Pfropfcopolymeren in Kombination mit Hydroxy-, Amid-, oder Esterfunktionen enthaltenden Komponenten |
ES2327034T3 (es) | 2002-03-26 | 2009-10-23 | Euro-Celtique S.A. | Composiciones recubiertas con gel de liberacion sostenida. |
WO2003086343A2 (en) | 2002-04-05 | 2003-10-23 | Cadila Healthcare Limited | Fast disintegrating oral dosage forms |
MY128945A (en) * | 2002-04-16 | 2007-03-30 | Kowa Co | Solid dispersion composition |
NZ537253A (en) | 2002-05-22 | 2007-09-28 | Boehringer Ingelheim Pharma | Coated pharmaceutical compositions containing flibanserin polymorph A |
US20040037869A1 (en) | 2002-08-16 | 2004-02-26 | Douglas Cleverly | Non-animal product containing veterinary formulations |
GB0219516D0 (en) | 2002-08-21 | 2002-10-02 | Phoqus Ltd | Fast dissolving and taste masked oral dosage form comprising sildenafil |
US20040097484A1 (en) | 2002-11-14 | 2004-05-20 | Marc Cantillion | Once a day galantamine pharmaceutical compositions and methods of use |
EP1575604B1 (en) | 2002-12-19 | 2006-12-06 | Council Of Scientific And Industrial Research | Antiulcer herbal composition(s) |
JP2006513238A (ja) | 2002-12-19 | 2006-04-20 | ファルマシア・コーポレーション | 吸湿性薬物を含む非‐吸湿性製剤 |
CN100339127C (zh) | 2002-12-30 | 2007-09-26 | 科学和工业研究委员会 | 止咳、镇咳和润喉草药制剂的研制 |
EP1594479A1 (en) | 2003-01-31 | 2005-11-16 | Ranbaxy Laboratories Limited | Stable oral benzimidazole compositions and processes for their preparation |
WO2004082664A1 (en) | 2003-03-21 | 2004-09-30 | Ranbaxy Laboratories Limited | Water-soluble tablets of metformin |
WO2004089343A1 (en) | 2003-04-09 | 2004-10-21 | Ranbaxy Laboratories Limited | Water soluble tablets |
KR100503949B1 (ko) | 2003-04-28 | 2005-07-26 | 주식회사유한양행 | 염산 온단세트론의 쓴맛을 효과적으로 은폐한 경구용 구강속붕해정 조성물 |
DE10319450A1 (de) | 2003-04-30 | 2004-11-18 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmazeutische Formulierung des Telmisartan Natriumsalzes |
EP1648411A4 (en) | 2003-07-10 | 2010-03-10 | Glaxosmithkline Llc | PHARMACEUTICAL COMPOSITIONS |
TW200507882A (en) | 2003-07-17 | 2005-03-01 | Kyowa Hakko Kogyo Kk | Solid formulations |
WO2005009407A2 (en) | 2003-07-29 | 2005-02-03 | Ranbaxy Laboratories Limited | Oral pharmaceutical formulations of olanzapine |
KR100604034B1 (ko) | 2003-10-08 | 2006-07-24 | 주식회사유한양행 | 암로디핀 유리염기를 함유한 구강 속붕해정 및 그의 조성물 |
WO2005041941A2 (en) | 2003-11-03 | 2005-05-12 | Zentiva, A.S. | Valsartan containing formulation |
WO2005051489A2 (en) | 2003-11-28 | 2005-06-09 | Ranbaxy Laboratories Limited | Fast dissolving solid oral dosage forms of galanthamine |
US20050142193A1 (en) | 2003-12-31 | 2005-06-30 | Lijuan Tang | Galantamine formulations |
US20050191349A1 (en) | 2003-12-31 | 2005-09-01 | Garth Boehm | Galantamine formulations |
US20060222677A1 (en) | 2004-01-14 | 2006-10-05 | Bianca Baroli | Method of protecting sensitive molecules from a photo-polymerizing environment |
WO2005082330A2 (en) | 2004-02-19 | 2005-09-09 | Ranbaxy Laboratories Limited | Co-precipitated amorphous cefditoren pivoxil and dosage forms comprising the same |
WO2005082331A2 (en) | 2004-02-26 | 2005-09-09 | Ranbaxy Laboratories Limited | Extended release tablets of clarithromycin |
CA2569964A1 (en) | 2004-06-10 | 2005-12-29 | Duramed Pharmaceuticals, Inc. | Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same |
WO2005123041A1 (en) | 2004-06-18 | 2005-12-29 | Yuhan Corporation | Oral dispersible tablet composition of amoxycillin and/or clavulanic acid comprising a surface-modified sodium bicarbonate |
US20060127479A1 (en) | 2004-10-08 | 2006-06-15 | Natrajan Kumaraperumal | Solvent free taste masked pharmaceutical compositions |
WO2006101536A1 (en) | 2004-11-04 | 2006-09-28 | Akina, Inc. | Fast-melting tablets having taste-masking and sustained release properties |
US20060159747A1 (en) | 2004-12-17 | 2006-07-20 | Boehringer Ingelheim International Gmbh | Telmisartan and hydrochlorothiazide combination therapy |
CA2601755C (en) | 2005-02-03 | 2014-07-29 | Nycomed Pharma As | Melt granulation of a composition containing a calcium-containing compound |
BRPI0606187A2 (pt) | 2005-02-25 | 2009-06-09 | Hoffmann La Roche | comprimidos com capacidade de dispersão da substáncia do fármaco melhorada |
GB0504203D0 (en) | 2005-03-01 | 2005-04-06 | Novartis Ag | Organic compounds |
WO2006113631A2 (en) | 2005-04-18 | 2006-10-26 | Rubicon Research Pvt. Ltd. | Bioenhanced compositions |
US20070014853A1 (en) | 2005-07-15 | 2007-01-18 | Ilan Zalit | Pharmaceutical dosage form containing novel pharmaceutical granulate |
JP2009511627A (ja) | 2005-10-17 | 2009-03-19 | マリンクロッド・インコーポレイテッド | 錠剤マトリックスにおけるゾルピデムの多形転移 |
UA95093C2 (uk) | 2005-12-07 | 2011-07-11 | Нікомед Фарма Ас | Спосіб одержання кальцієвмісної сполуки |
PL1842534T3 (pl) | 2006-02-24 | 2012-05-31 | Teva Pharma | Tabletki bursztynianu metoprololu o przedłużonym uwalnianiu oraz sposoby ich wytwarzania |
WO2007096906A2 (en) | 2006-02-27 | 2007-08-30 | Panacea Biotec Ltd. | Novel buccoadhesive compositions and process of preparation thereof |
GB0610570D0 (en) | 2006-05-27 | 2006-07-05 | Pliva Istrazivanje I Razvoj D | Novel formulation |
US20100297226A1 (en) * | 2006-06-01 | 2010-11-25 | Dexcel Pharma Technologies Ltd. | Multiple unit pharmaceutical formulation |
US8568785B2 (en) | 2006-07-19 | 2013-10-29 | Asahi Kasei Chemicals Corporation | Process for producing spherical base granule comprising easily water-soluble drug |
CN100438917C (zh) * | 2006-07-20 | 2008-12-03 | 山东聊城阿华制药有限公司 | 一种微晶纤维素乳糖的制备方法 |
DE102008047910A1 (de) | 2008-09-19 | 2010-03-25 | Molkerei Meggle Wasserburg Gmbh & Co. Kg | Tablettierhilfsstoff auf Laktose- und Cellulosebasis |
-
2008
- 2008-09-19 DE DE102008047910A patent/DE102008047910A1/de not_active Withdrawn
-
2009
- 2009-09-21 US US13/119,945 patent/US8663684B2/en active Active
- 2009-09-21 KR KR1020117008931A patent/KR101661256B1/ko active IP Right Grant
- 2009-09-21 WO PCT/EP2009/062203 patent/WO2010031866A1/de active Application Filing
- 2009-09-21 MX MX2011002950A patent/MX337357B/es active IP Right Grant
- 2009-09-21 CN CN200980142138.2A patent/CN102202691B/zh active Active
- 2009-09-21 UA UAA201104469A patent/UA102865C2/ru unknown
- 2009-09-21 CA CA2737380A patent/CA2737380C/en active Active
- 2009-09-21 BR BRPI0918530-5A patent/BRPI0918530B1/pt active IP Right Grant
- 2009-09-21 EP EP09736157.0A patent/EP2344197B1/de active Active
- 2009-09-21 ES ES09736157.0T patent/ES2624231T3/es active Active
- 2009-09-21 NZ NZ592331A patent/NZ592331A/xx unknown
-
2011
- 2011-03-16 ZA ZA2011/01982A patent/ZA201101982B/en unknown
Also Published As
Publication number | Publication date |
---|---|
US8663684B2 (en) | 2014-03-04 |
WO2010031866A1 (de) | 2010-03-25 |
CA2737380C (en) | 2017-04-11 |
CN102202691A (zh) | 2011-09-28 |
DE102008047910A8 (de) | 2010-07-08 |
ES2624231T3 (es) | 2017-07-13 |
KR20110063549A (ko) | 2011-06-10 |
CA2737380A1 (en) | 2010-03-25 |
ZA201101982B (en) | 2011-11-30 |
MX2011002950A (es) | 2011-08-03 |
NZ592331A (en) | 2012-10-26 |
US20110207826A1 (en) | 2011-08-25 |
UA102865C2 (ru) | 2013-08-27 |
EP2344197B1 (de) | 2017-04-05 |
EP2344197A1 (de) | 2011-07-20 |
BRPI0918530B1 (pt) | 2019-06-04 |
KR101661256B1 (ko) | 2016-09-30 |
BRPI0918530A2 (pt) | 2015-12-08 |
CN102202691B (zh) | 2014-03-26 |
DE102008047910A1 (de) | 2010-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2011008262A (es) | Espiroamidas sustituidas como moduladores de b1r:. | |
MX2011009369A (es) | 2-mercaptoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3. | |
CL2008001897A1 (es) | Proceso para la preparacion de 3-halometil-1-metil-1h-pirazol, utiles como intermediario en la produccion de fungicidas; compuestos derivados de 3-halometil-1-metil-1h-pirazol. | |
UA102865C2 (ru) | Вспомогательные вещества для таблетирования на основе лактозы и целлюлозы | |
IN2012DN02751A (es) | ||
MY197904A (en) | Method for producing substituted 5-fluoro-1h-pyrazolopyridines | |
MX2018008597A (es) | Composiciones inyectables de melfalan que comprenden un derivado de ciclodextrina y metodos de fabricacion y uso de las mismas. | |
UA86731C2 (ru) | Делимая галеновая форма модифицированного высвобождения активного ингредиента | |
MY163339A (en) | A method of producing ingenol-3-angelate | |
EP2130909A4 (en) | METHOD OF PRODUCING TOOTH AND TOOTH PRODUCED BY THE METHOD | |
WO2010015657A3 (en) | Alkoxypyrazoles and the process for their preparation | |
MX2011008825A (es) | 3-aminoisoxazolopiridinas sustituidas como moduladores de kcnq2/3. | |
MX344246B (es) | Procedimiento para la preparacion de cloruros de acido 5-fluoro-1-alquil-3-fluoroalquil-1h-pirazol-4-carboxilico. | |
UA101835C2 (uk) | Спосіб отримання похідних 1-(2-галогенбіфеніл-4-іл)-циклопропанкарбонової кислоти | |
MX2011008662A (es) | 2-mercapto-3-aminopiridinas sustituidas como moduladores de kcnq2/3. | |
MX2011009338A (es) | 3-amino-2-mercaptoquinolinas sustituidas como moduladores de kcnq2/3. | |
MX362689B (es) | Procedimiento de preparacion de derivados de acido 3,5-bis(fluoroalquil)pirazol-4-carboxilico y 3,5-bis(fluoroalquil) pirazoles. | |
TW201129620A (en) | New formaldehyde scavengers | |
WO2007132354A3 (en) | Process for preparing voriconazole, new polymorphic form of intermediate thereof, and uses thereof | |
UA106619C2 (uk) | Спосіб отримання похідних 1-(2-галогенбіфеніл-4-іл)-циклопропанкарбонової кислоти | |
SG10201805749QA (en) | Substantially animal protein-free recombinant furin and methods for producing same | |
MY158910A (en) | Surface modified silicic acid semi-gels | |
PL2300606T3 (pl) | Sposób wytwarzania hydrolizatu kazeiny | |
WO2008075205A3 (en) | Improved process for the preparation of voriconazole | |
EA201390336A1 (ru) | Способ получения промежуточного соединения для синтеза лекарственного средства |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |